ACG releases new guidelines for benign anorectal disorders | Study: Diagnostic test better for cirrhosis exclusion than detection | G-CSF treatment improves liver function in alcoholic hepatitis
Web Version
 
July 21, 2014
CONNECT WITH ACG®  FacebookTwitter
ACG SmartBrief
ACG SmartBrief is an official publication of the ACG.
FORWARD|ARCHIVE

Clinical Updates
ACG releases new guidelines for benign anorectal disorders
Updated American College of Gastroenterology guidelines on managing benign anorectal disorders related to function or structure include scientific data through 2013. The recommendations, published in The American Journal of Gastroenterology, cover defecatory disorders, chronic proctalgia, proctalgia fugax, fecal incontinence, anal fissures and hemorrhoids. Read the abstract. Healio (free registration) (7/18), BeckersASC.com (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
Study: Diagnostic test better for cirrhosis exclusion than detection
Data analysis from 16 studies showed a noninvasive diagnostic test, FibroTest, had a low accuracy rating for detecting significant fibrosis and cirrhosis in patients with chronic hepatitis B, researchers reported in The American Journal of Gastroenterology. Researcher Dr. Nermin Salkic said the test is a good tool for excluding cirrhosis in HBV patients but its ability to detect fibrosis and cirrhosis and exclude fibrosis is suboptimal. Read the abstract. Healio (free registration) (7/15)
Share: LinkedInTwitterFacebookGoogle+Email
G-CSF treatment improves liver function in alcoholic hepatitis
Standard medical therapy plus granulocyte colony-stimulating factor improved liver function and overall survival of patients with severe alcoholic hepatitis, according to a study in The American Journal of Gastroenterology. Patients who received the combination therapy showed improved CD34+ cells in peripheral blood after five days of treatment and reduced median change percentages in MELD, Child-Turcotte-Pugh and modified Maddrey's discriminant function scores at one, two and three months compared with those who received standard therapy only. Read the abstract. Healio (free registration) (7/18)
Share: LinkedInTwitterFacebookGoogle+Email
Study finds raltegravir safe for ESLD and after transplant
Raltegravir was well-tolerated in patients with HIV who had liver transplants or end-stage liver disease, according to a 15-patient study. Among transplant patients, there were no interactions between immunosuppressive drugs and raltegravir. Healio (free registration)/Infectious Disease News (7/15)
Share: LinkedInTwitterFacebookGoogle+Email
 
Legal & Regulatory
CMS proposes quality measure for outpatient colonoscopy
The 2015 Outpatient Prospective Payment System includes a proposal to track Medicare beneficiaries who go to the hospital because of adverse events linked to outpatient colonoscopies. The proposed CMS rule, which would take effect in 2017 and be publicly reported, would create a new quality measure for hospital outpatient centers to evaluate complications such as perforation of the colon, gastrointestinal bleeding or a cardiopulmonary event within a week following colonoscopy. HealthLeaders Media (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
ACG note: ACG is reviewing and will be providing comments to CMS on this new measure for both the Medicare hospital outpatient department and ambulatory surgical center quality reporting programs.
Share: LinkedInTwitterFacebookGoogle+Email
Practice News
Gastroenterologists say price transparency helps patients
Price transparency is an important issue for patients making health care decisions, gastroenterologists say. Tools should be developed by gastroenterologists, payers and government agencies to offer clear, accessible data that people can use to compare physicians, said Dr. Maxwell Chait of ColumbiaDoctors Medical Group in Hartsdale, N.Y. BeckersASC.com (7/18)
Share: LinkedInTwitterFacebookGoogle+Email
More UC treatments offer alternatives to steroids, physician says
There is a broader range of ulcerative colitis treatments than ever before, and additional drug candidates are in late-stage testing, signaling an end to steroids being the only UC therapy option, according to Dr. William Sandborn, head of the Division of Gastroenterology at the University of California, San Diego. He said approval of three tumor necrosis factor-alpha antagonist treatments in nine years is a big step forward for UC patients. Healio (free registration) (7/18)
Share: LinkedInTwitterFacebookGoogle+Email
Business & Market Trends
Poll shows physicians have mixed views on EHR use
Data from a Medscape survey showed 63% of responding physicians agreed that EHR adoption improves documentation, while 39% said the practice boosts collections, 34% said it helps clinical operations and 32% said it boosts patient service. On the opposing side, 27% said EHRs worsen documentation, while 9% said EHRs result in worse collections, 38% said they had negative effects on patient service and 35% said they were detrimental to clinical operations. BeckersHospitalReview.com (7/17)
Share: LinkedInTwitterFacebookGoogle+Email
Patient's Perspective
Survey examines patient preference on health reminders
A survey by analytics firm FICO revealed 41% of patients preferred phone calls as appointment reminders, while 33% chose e-mails and 12% chose text messages. Researchers also found 40% of respondents preferred using e-mails as reminders to schedule appointments and health checks, compared with only 23% for phone calls and 13% for standard mail. Mobile health applications and social media did not prove to be popular when it comes to such functions, researchers added. BeckersHospitalReview.com (7/16)
Share: LinkedInTwitterFacebookGoogle+Email
ACG News
ACG 2014. Designed with the busy GI clinician in mind
Too busy to step away from the office? Think again. A couple of days out of the office to learn the latest clinical updates and how to apply them to patient care may be just what you need to feel refreshed and re-energized about your profession. As one past attendee stated about the meeting, "Enjoyable, informative meeting with many excellent scientific presentations; many worthwhile practical take home points for clinical practice." Join colleagues for one day for optional Friday courses, two days for the weekend Postgraduate Course, three days for the Annual Scientific Meeting, or a combination of the three. Registration and housing are open. ACG 2014 will take place October 17 to 22 at the Pennsylvania Convention Center in Philadelphia. Learn more about the educational program. Register for ACG 2014.
Share: LinkedInTwitterFacebookGoogle+Email
New Antithrombotics: The GI Endoscopist's Perspective
Evaluate the newer antithrombotic agents in the context of peri-endoscopic management when you attend the ACG Midwest Regional Postgraduate Course, Aug. 22 to 24 at the Sheraton City Centre Hotel in Indianapolis. Other topics to be offered include: Non-Dietary Interventions for Irritable Bowel Syndrome, Chronic Pancreatitis: Expert Tips and Tricks, Optimizing Current Anti-TNF Therapy in Clinical Practice, Screening for Colorectal Cancer in the Elderly, and more. Attend and you can earn up to 12.25 hours of CME. Registration is now open. Review the course brochure and register today.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
Be brave enough to start a conversation that matters."
-- Margaret Wheatley,
American writer
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about ACG® ->Homepage | Meetings | Resources | National Affairs
Digestive Health Resources
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tara Rosenzweig
Advertising:  Hillary Batchelder
  P: 202.407.7803
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information